Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (1-10 of 336) with videos related to

Pageof 34
Sort By:
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
A closer look at copanlisibMartin Dreyling
Therapeutische Umschau. Revue Therapeutique|October 2, 2010
[Current clinical aspects of follicular lymphoma]Martin Dreyling
Blood|August 24, 2017
Combined therapy in MCL: less may be more?Martin Dreyling
The Lancet. Haematology|December 28, 2020
The M factor: maintenance in mantle cell lymphomaMartin Dreyling
Seminars in Hematology|July 26, 2011
Therapy of mantle cell lymphoma: new treatment options in an old disease or vice versa?Martin Dreyling
Leukemia & Lymphoma|January 19, 2008
Combination of biologicals in indolent lymphoma: finally the end of chemotherapy era in indolent lymphoma?Martin Dreyling
Leukemia & Lymphoma|May 3, 2008
Hyper-CVAD in mantle-cell lymphoma: really "hyper" or just hype?Martin Dreyling
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Mantle cell lymphoma: biology, clinical presentation, and therapeutic approachesMartin Dreyling,
Nature Reviews. Clinical Oncology|May 27, 2015
Haematological cancer: Bortezomib in MCL--new standard of care or just another option?Martin Dreyling
Hemasphere|April 21, 2020
EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone LymphomasMarco Ladetto, Martin Dreyling
Pageof 34

Showing results (1-10 of 336) with videos related to

Sort By:
Pageof 34
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
A closer look at copanlisibMartin Dreyling
Therapeutische Umschau. Revue Therapeutique|October 2, 2010
[Current clinical aspects of follicular lymphoma]Martin Dreyling
Blood|August 24, 2017
Combined therapy in MCL: less may be more?Martin Dreyling
The Lancet. Haematology|December 28, 2020
The M factor: maintenance in mantle cell lymphomaMartin Dreyling
Seminars in Hematology|July 26, 2011
Therapy of mantle cell lymphoma: new treatment options in an old disease or vice versa?Martin Dreyling
Leukemia & Lymphoma|January 19, 2008
Combination of biologicals in indolent lymphoma: finally the end of chemotherapy era in indolent lymphoma?Martin Dreyling
Leukemia & Lymphoma|May 3, 2008
Hyper-CVAD in mantle-cell lymphoma: really "hyper" or just hype?Martin Dreyling
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Mantle cell lymphoma: biology, clinical presentation, and therapeutic approachesMartin Dreyling,
Nature Reviews. Clinical Oncology|May 27, 2015
Haematological cancer: Bortezomib in MCL--new standard of care or just another option?Martin Dreyling
Hemasphere|April 21, 2020
EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone LymphomasMarco Ladetto, Martin Dreyling
Pageof 34